Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Aug 25;15(8):e0237313. doi: 10.1371/journal.pone.0237313

Causes of morbidity and mortality among patients admitted in a tertiary hospital in southern Nigeria: A 6 year evaluation

Henshaw Uchechi Okoroiwu 1,*, Kingsley Ikenna Uchendu 2, Rita A Essien 3
Editor: Chiara Lazzeri4
PMCID: PMC7447063  PMID: 32841255

Abstract

Background

Data on morbidity and mortality are essential in assessing disease burden, monitoring and evaluation of health policies. The aim of this study is to describe the causes of morbidity and mortality in the wards of University of Calabar Teaching Hospital (UCTH).

Methods

The study took a retrospective approach evaluating causes of morbidity and mortality from 2012–2017. Causes of death were documented based on International Classification of Disease 10 (ICD-10). Data were retrieved from health records department, UCTH.

Results

Overall, 2,198 deaths were recorded out of the 49,287 admissions during the study period giving a mortality rate of 4.5% comprising 1,152 (52.4%) males and 1,046 (47.6%) females. A greater number of males were admitted via accident and emergency. Age group 15–45 years had the highest number of admissions (57.9%) and deaths (37.7%), while age group >65 years recorded the highest number of deaths per admission (9.7% mortality rate). The broad leading causes of death were infectious and parasitic disease and diseases of the circulatory system (cardiovascular diseases) accounting for 22.7% and 15.8% of all deaths, respectively. However, diseases of the circulatory system recorded the highest number of deaths per admission (13.7% mortality rate). Overall, infectious diseases were the chief cause of mortality in adults while conditions originating from perinatal period were the major cause of death in children. Septicemia (6.0%), stroke (4.2%), liver diseases (4.1%), tuberculosis (3.7%), diabetes (3.6%) and HIV/AIDS (3.4%) were the specific leading cases of deaths. Sepsis, chronic diseases of the tonsil and adenoids and malaria were the specific leading causes of death in children, while sepsis, stroke and liver diseases were the leading cause of death in adults.

Conclusion

Most causes of deaths in this study are preventable. This study revealed double burden of communicable and non-communicable diseases.

Background

Causes of morbidity and mortality are relevant parameters for documentation of the geographical burden of disease and for public health planning, involving programmatic needs, assessing intervention programmes, and reevaluation of health policies [1]. They are also relevant tools for keeping track of the health of populations as well as for effective response to changing epidemiological trends [24]. More so, they serve as tool for quality control of health care system. For instance, deaths that occur due to causes that should otherwise not be fatal at the instance of effective medical practice, known as amenable mortality is an indicator of national levels of personal health-care access and quality [2,5].

Globally, there were 56.9 million deaths in 2016 from varying causes among different regions [6]. Ischemic heart disease and stroke are the global leading causes of death, accounting for a combined 15.2 million deaths in 2016 and have remained the leading causes of death globally in the prior 15 years [6]. The global burden of disease study 2017 reported ischemic heart disease, neonatal disorders and stroke as leading causes of early death [7]. Greater proportion of developing countries have mortality pattern that show larger proportion of infectious disease and the risk of death during pregnancy and childbirth whereas cardiovascular diseases, chronic respiratory diseases and cancers account for most deaths in the developed world [8]. Population-based data on pattern of morbidity and mortality are often lacking in developing countries, hospital based pattern of morbidity and mortality often offer best alternative [4].

Most mortality reviews in Nigeria emanated from the south-west [913], north [14,15] and south east [16]. There is a paucity of data on morbidity and mortality pattern in the southern region. Hence, this study is aimed at bridging this gap by reviewing comprehensive data on morbidity and mortality in a tertiary institution in southern Nigeria.

Methods

Study design

This study took a retrospective descriptive cross-sectional method in analyzing causes of morbidity and mortality in University of Calabar Teaching Hospital (UCTH) from January 2012 to December, 2017.

Study area

This study was conducted at University of Calabar Teaching Hospital, Calabar Cross River State, Nigeria, which is a 410 bed space capacity tertiary health care institution. The hospital is made up of 15 wards and 11 clinics. It is generally stratified into health care service department and administrative department, mortuary services and laundry and tailoring unit. The health care services is composed of laboratory department, nursing services, surgery, internal medicine, family medicine, pediatrics, obstetrics and gynecology, ophthalmology, physiotherapy, food and nutrition, orthopedics, accident and emergency, dental department, dialysis and blood bank units [17,18]. Though there is no published annual admission and mortality data, there are more than 2000 deliveries annually in the centre [19]. Cross River State is one of the states that form the southern part of Nigeria with an area of 21,787km2 and a population of 2,892,988 (using the 2006 census) [20,21]. The hospital is sited in Calabar metropolis which is a fusion of Calabar Municipality and Calabar South Local Government Areas (Fig 1) [22]

Fig 1. Map of the studied area.

Fig 1

Study population

Patients who were admitted or died (while in admission) within 2012 and 2017 were included in the study. More so, it is pertinent to note that female subjects admitted for labour and delivery were part of the study population. Patients brought in dead before arrival were excluded.

Data collection

Data on demographics, causes of mortality and morbidity were retrospectively extracted from the health records department of the University of Calabar Teaching Hospital where they are coded based on international classification of disease– 10 (ICD—10) [23]. The various ICD classifications were allotted by the staff of health record department. The data are usually updated daily via outgone and returning patient case notes (folder) and are compiled into quarterly report submitted to Medical Advisory Committee. The data entry into spreadsheet from the original report book was performed with the assistance of 6 trained research assistants.

Ethics approval

This study was approved by Health Research Ethical Committee (HREC) of the University of Calabar Teaching Hospital.

Statistical analysis

Data generated in this study were entered and analyzed using SPSS version 22 (IBM Corps, Armonk, NY, USA). Frequencies and Percentages were used to represent the categorical variables. Pearson Chi square test was used to assess association between variables. Mantel Haenzel test of trend was used to assess linear association. Odd ratio was used to assess odd of occurrence in categorical variables. Alpha value was set at 0.05.

Results

A total of 49,287 patients were admitted into the wards and accident and emergency (casualty ward) during the period of study. Of these, 2,198 died giving a mortality rate of 4.5%. Gender stratification showed that 1,152 (7.4%) out of 15,622 males admitted died while 1,046 (3.1%) of the 33,665 of the females admitted died. Mortality was significantly higher in male gender than their female counterparts with odd ratio of 2.483 (2.278–2.704). Further stratification of the admitted patients based on route of admission showed that 37.0% of the patients were admitted via casualty (accident and emergency) while 63.0% were admitted via wards. A greater proportion of the males (59.8%) were admitted via casualty while the reverse was the case for the female patients (as they were admitted more via the ward; family medicine). The disparity was statistical significant (P< 0.05) (Table 1).

Table 1. Frequency of morbidity and mortality of the studied population based on gender.

Gender N. admitted (%) Deaths (%) M. rate (%) X2 OR P-value CI
Male 15,622 (31.7) 1,152 (52.4) 7.4 456.008 2.483 <0.01 2.278–2.704
Female 33,665 (68.3) 1,046 (47.6) 3.1 1
Total 49,287 (100.0) 2,198 (100.0) 4.5
Admission route
Via ward (%) Via casualty (%) (jjjjj(% % % 5108.04 <0.01
Male 6,280 (40.2) 9,342 (59.8)
Female 24,778 (73.6) 8,887 (26.4)
Total 31,058 (63.0) 18,229 (37.0)

N.: absolute number

M.: mortality

Table 2 shows the distribution of frequency of morbidity and mortality of the patients within the study period based on age. Age range 15–45 years had the highest number (57.9%) of admissions followed by 1–4 years (11.7%) and < 1 year (11.3%) age range. On the other hand, age range 15–45 years recorded the highest number (37.7%) of deaths followed by the 46–64 (23.8%) and the > 65 years (16.1%) category. However, the age range > 65 years recorded the highest number of deaths per admission giving rise to 16.5% mortality rate. The mortality rate increased as the age increased. The linear association was found to be significant (p<0.05) using Mantel Haenzel test for trend (Table 2).

Table 2. Frequency of morbidity and mortality of the studied population based on age.

Age (years) Admissions (%) Deaths (%) M. rate (%) X2 Df P-value
<1 5,652 (11.5) 253 (11.5) 4.5 4887.235a 5 0.000
1–4 5,764 (11.7) 138 (6.3) 2.4 2973.53b 1 0.000
5–14 2,954 (6.0) 102 (4.6) 3.4
15–45 28,535 (57.9) 829 (37.7) 2.9
46–64 4,255 (8.6) 523 (23.8) 12.3
≥65 2,127 (4.3) 353 (16.1) 16.6

M.: mortality

a: Pearson Chi-square coefficient

b: Mantel Haenzel test for trend (linear by linear association)

Mortality rates for the years 2012, 2013, 2014, 2015, 2016 and 2017 were found to be 3.6%, 3.9%, 4.1%, 4.2%, 6.1% and 5.1% respectively (Fig 2).

Fig 2. Mortality rates of the studied years (2012–2017).

Fig 2

Table 3 shows the causes of morbidity and mortality of the studied patient based on the broad ICD-10 classification. The broad ICD overall leading causes of death were infectious diseases and parasitic infections, and diseases of the circulatory system accounting for 22.7% and 15.8% of all deaths. However, diseases of the circulatory system recorded the highest number of deaths per admission (348/2,540) giving a mortality rate of 13.7%. Infectious diseases and parasitic infections were the leading causes of death in adults while conditions originating from perinatal period was the leading cause of death in children.

Table 3. Distribution of causes of morbidity and mortality by broad ICD-10 classification.

Disease diagnostic category (ICD-10 code) Children (0–14 years) Adult (≥15 years) Total Adm. Total death
Admission Death Admission Death
Infectious and parasitic diseases 3,332 106 1,578 392 4,910 498 (22.7)
Neoplasms 86 8 1,303 110 1,392 118 (5.4)
Disease of blood & blood forming organs 549 6 415 61 964 67 (3.0)
Endocrine, nutritional & metabolic diseases 859 24 857 90 1,716 114 (5.2)
Mental and behavioral disorders 11 0 82 13 93 13 (0.6)
Diseases of the nervous system 276 27 539 106 815 133 (6.0)
Eye and adnexa diseases 162 0 300 0 462 0 (0.0)
Ear and mastoid process 97 1 31 0 128 1 (0.0)
Circulatory system diseases 239 27 2,301 321 2,540 348 (15.8)
Respiratory system diseases 3,382 40 595 78 3,977 118 (5.4)
Diseases of the digestive system 325 17 1,839 165 2,164 182 (8.3)
Diseases of the skin and subcutaneous tissue 300 9 277 31 577 40 (1.8)
Diseases of musculoskeletal system & connective tissue 114 10 282 13 396 23 (1.0)
Diseases of the genitourinary system 299 17 1,397 105 1,626 122 (5.5)
Pregnancy, childbirth & puerperium 10 1 16,108 18 16,118 19 (0.9)
Condition originating in the perinatal period 2,497 123 1,752 2 4,249 125 (5.7)
Congenital malformations 330 33 76 6 406 39 (1.8)
Symptoms, signs and abnormal clinical and laboratory findings 636 15 639 88 1,275 103 (4.7)
Injury and poison & other external causes 575 24 1,800 83 2,375 107 (4.9)
Factors influencing health status & contact with health services 331 7 2,773 21 3,104 28 (1.3)

Adm.: admission

Table 4 shows further stratification of the specific causes of death within the broad ICD 10 classification based on adult and children classification.

Table 4. Distribution of causes of morbidity and mortality by broad ICD-10 classification and specific disease types.

Diagnostic category (ICD-10 code) Children (0–14 years) Adult (≥15 years) Total Adm. Total death
Admission Death Admission Death
Infectious and parasitic diseases
Infectious and parasitic diseases
n = 498 (22.7)
 Diarrhea & gastroenteritis 1,154 17 131 14 1,285 31 (6.2)
 Septicaemia 327 38 269 94 596 132 (26.5)
 HIV 99 7 324 68 423 77 (15.5)
 Other viral diseases 46 1 244 75 290 76 (15.3)
 Malaria 1,450 23 145 10 1,595 33 (6.6)
 Tuberculosis 69 2 233 79 302 81 (16.3)
 Others 187 16 232 52 419 68 (13.6)
Neoplasms n = 118 (5.4)
 Malignant neoplasm of lip, oral cavity 1 0 19 0 20 0 (0.0)
 Malignant neoplasm of liver 1 0 58 20 59 20 (16.9)
 Malignant neoplasm of breast 3 0 141 20 144 20 (16.9)
 Malignant neoplasm of cervix & uteri 0 0 91 4 91 4 (3.4)
 Benign neoplasm of breast 1 0 19 0 20 0 (0.0)
 Leiomyoma of uteri 0 0 350 0 350 0 (0.0)
 Others 80 8 628 66 708 74 (62.7)
Disease of blood & blood forming organs n = 67 (3.0)
 Anemia 535 5 379 56 914 61 (91.)
 Others 14 1 36 5 50 6 (9.0)
Endocrine, nutritional & metabolic diseases n = 114 (5.2)
 Diabetes mellitus 15 0 664 78 679 78 (68.4)
 Malnutrition 135 13 9 1 144 14 (12.3)
 Volume depletion 656 6 16 0 672 6 (5.5)
 Others 53 5 168 11 221 16 (4.0)
Mental and behavioral disorders n = 13 (0.6)
Diseases of the nervous system n = 133 (6.0)
 Inflammation disease of the CNS 139 19 130 30 269 49 (36.8)
 Cerebral palsy & other paralytic syndromes 19 0 203 50 222 50 (37.6%)
 Others 118 8 206 26 324 34 (25.6)
Diseases of the eye and adnexa diseases n = 0 (0.0)
Diseases of the ear and mastoid process n = 1 (0.0)
Circulatory system diseases n = 348 (15.8)
 Essential (primary) hypertension 11 1 274 25 285 26 (7.5)
 Other hypertensive diseases 6 0 301 28 307 28 (8.0)
 Ischaemic heart disease 128 18 547 56 675 74 (21.3)
 Stroke 1 0 308 93 309 93 (26.7)
 Others 93 8 871 119 964 127 (36.5)
Respiratory system diseases n = 118 (5.4)
 Acute pharyngitis and tonsillitis 1018 1 30 0 1048 1 (0.8)
 Other acute respiratory infections 500 0 43 1 543 1 (0.8)
 Pneumonia 790 7 110 9 900 16 (13.6)
 Acute bronchitis 123 0 1 0 124 0 (0.0)
 Chronic disease of the tonsils & adenoids 388 26 21 0 409 26 (22.0)
 Asthma 372 1 51 0 323 1 (0.8)
 Others 291 5 339 68 630 73 (61.9)
Diseases of the digestive system n = 182 (8.3)
 Gastric and duodenal ulcer 18 0 201 10 219 10 (5.5)
 Diseases of the appendix 45 0 336 2 381 2 (1.1)
 Inguinal hernia 63 0 274 11 337 11 (6.1)
 Paralytic ileus & intestinal obstruction 65 5 117 8 182 13 (7.1)
 Alcohol liver disease 0 0 11 4 11 4 (2.2)
 Other diseases of the liver 15 3 305 84 320 87 (7.8)
 Others 119 9 595 46 714 55 (30.2)
Diseases of the skin & subcutaneous tissue n = 40 (1.8)
Diseases of musculoskeletal system & connective tissue n = 23 (1.0)
Diseases of the genitourinary system n = 122 (5.5)
 Acute nephritic syndrome 42 10 241 40 283 50 (41.0)
 Real tubule interstitial 3 3 102 12 141 15 (12.3)
 Other diseases of the urinary system 99 4 349 46 448 50 (41.0)
 Others 53 0 705 7 758 7 (5.7)
Pregnancy, childbirth & puerperium n = 19 (0.9)
 Medical abortion 0 0 506 5 506 5 (26.3)
 Post-partum hemorrhage 2 0 759 1 761 1 (5.3)
 Single spontaneous delivery 3 0 5,717 1 5717 1 (5.3)
 Others 5 1 9,130 11 9,135 12 (63.1)
Condition originating in the perinatal period n = 125 (5.7)
 Fetus affected by maternal factors & Labor 25 0 1,005 0 1,030 0
 Slow fetal growth, malnutrition & short gest. 330 21 82 0 412 16.8
 Congenital infectious & parasitic diseases 867 23 231 1 1,098 19.2
 Others 1,275 79 434 1 1,709 64.0
Congenital malformations n = 39 (1.8)
Symptoms, signs and abnormal clinical and laboratory findings n = 103 (4.7)
Injury and poison & other external causes n = 107 (4.9)
 Fracture of limb bone 40 0 263 4 303 4 (3.7)
 Burns and corrosion 120 18 123 21 243 39 (36.5)
 Others 415 6 1,414 58 1,829 64 (59.8)
Factors influencing health status & contact with health services n = 28 (1.3)

On individual disease assessment of the causes of death, septicaemia (6.0%), stroke (4.2%), liver diseases (4.1%), tuberculosis (3.7%), diabetes (3.6%), complications of HIV/AIDS (3.5%) and ischaemic heart disease (3.4%) were the leading causes of mortality. Further stratification based on age showed malaria, diarrhea & gastroenteritis and acute pharyngitis and tonsillitis were the leading causes of admission while sepsis, chronic diseases of the tonsil and malaria were the leading causes of mortality in children. On the other hand, single spontaneous delivery, fetus affected by maternal factors & labor, post-partum hemorrhage (obstetric reasons) and diabetes mellitus (non-obstetric reason) were the leading causes of admission, while sepsis, stroke and liver diseases were the leading causes of death in adults (Table 5).

Table 5. Summary of the leading seven specific causes of mortality in the study.

Specific disease % of total deaths (%) Rank Specific disease
Children (0–14 years) Adult (≥15 years)
Admission (n = 14,370) % Deaths (n = 493) % Admission (n = 34,917) % Deaths (n = 1,705)
Sepsis 6.0 1st Malaria 10.0 Sepsis 7.7 Single spontaneous delivery 16.4 Sepsis 5.5
Stroke 4.2 2nd Diarrhea & gastroenteritis 8.0 Chronic disease of the tonsils & adenoids 5.3 Fetus affected by maternal factors & Labor 2.9 Stroke 5.4
Liver diseases 4.1 3rd Acute pharyngitis and tonsillitis 7.1 Malaria 4.7 Post-partum hemorrhage 2.2 Liver diseases 4.9
Tuberculosis 3.7 4th Congenital infection & parasitic diseases 6.0 Congenital infection & parasitic diseases 4.7 Diabetes 1.9 Tuberculosis 4.6
Diabetes 3.6 5th Pneumonia 5.5 Slow fetal growth, malnutrition & short gest. 4.2 Anemia 1.1 Diabetes 4.4
HIV 3.5 6th Volume depletion 4.6 Inflammation disease of the CNS 3.8 Leiomyoma of uteri 1.0 Other viral diseases 4.4
Other viral diseases 3.5 7th Anemia 3.7 Burns 3.6 Other diseases of the urinary system 0.9 HIV 4.0
Ischemic heart disease 3.4 8th Chronic disease of the tonsils & adenoids 2.7 Ischaemic heart disease 3.6 Diseases of the appendix 1.0 Ischemic heart disease 3.3
Acute nephritic syndrome 2.3 9th Asthma 2.6 Diarrhea & gastroenteritis 3.4 HIV 0.9 Anemia 3.3
Cerebral palsy & other paralytic syndromes 2.3 10th Slow fetal growth, malnutrition & short gest. 2.3 Malnutrition 2.6 Stroke 0.8 Cerebral palsy & other paralytic syndromes 2.9
Other diseases of urinary system 2.3

Discussion

In sub-Saharan Africa, population-based information are scarce, hence, hospital-based morbidity and mortality data has become relevant surrogates in assessing disease burden, quality of health care as well as policy making [16].

In this study, we observed mortality rate of 4.5%. This value is lower than 6.3% and 12.0% being studies in Ondo [13] and Kano [14], Nigeria. However, this observation is higher than an earlier hospital based study in Pakistan that reported mortality rate of 1.6% [24].

Gender stratification showed higher mortality in the male gender despite the higher admission rate of the females. This trend is similar to earlier reports from studies in Nigeria [4,14,] as well as another study in Ethiopia [25]. Generally, females have been shown to have lower mortality and relative longer life expectancy when compared to males [2628]. This disparity has been attributed to higher mortality through injuries in males in Africa, Latin America, Caribbean and Europe [29]. However, a closer observation in the mode of admission offers a clue on the gender based hazard and treatment seeking behavior of the males in the studied area. Despite consisting 31.7% of the total admissions, males topped (59.8%) admission via accident and emergency/casualty ward. More males tends to be drivers and are more likely to be victims of road accident, hence, emergency admission. More so, the cultural dogma of males being “bread winners” of their families cannot be ruled out as a contributing factor to deferred health seeking behaviors. However, the addition of admissions for labour and delivery which are not actually causes of morbidities may contribute to this disparity.

Majority (37.7%) of the death recorded in this study were observed in the 15–45 years age group. This pattern is similar to earlier reports from studies in other parts of Nigeria [4,16]. This observation is prevalent in most studies originating from Africa, mostly sub-Sahara Africa where life expectancy is short [4,16]. Life expectancy among Nigerians has shuttered between 57.2–65.9 years and 54.1–62.8 years for females and males, respectively [30].

Infectious and parasitic diseases were the leading causes of mortality in this study. The finding is in consonance with previous reports in developing countries [4,9,16,24,25]. This is also in agreement with the report of WHO 2004 Global Burden of disease for low income countries [25]. On further stratification, septicaemia, tuberculosis and complications of HIV were the chief causes of death due to infectious diseases accounting for 26.5, 16.3 and 15.5% of all deaths by infectious and parasitic disease, respectively. Sepsis (a consequence of septicaemia), a syndrome of deregulated host response to infection leading to life threatening organ dysfunction, is a major global health burden [31] causing about 5–6 million deaths annually with majority occurring in low and middle income countries [31,32]. Overall, septicaemia was the leading cause of both child and adult mortality and is responsible for 6.0% (132/2,198) of all deaths recorded in this study. Tuberculosis and complications of HIV accounted for 3.7 and 3.5% of the overall death becoming the 4th and 6th leading individual disease causes of death in this study. Both have been reported as the leading cause of death in sub-Saharan Africa [1,33,34]. Despite the decline trend in tuberculosis globally, multidrug resistant tuberculosis (MDR-TB) has encouraged the epidemic in low-income countries with the incidence rate not less than 20 times higher in-low income countries than their high income counterparts [3537]. Human immunodeficiency virus (HIV) on the other hand, has had its highest toll of epidemic in the sub-Saharan Africa with approximately 1 in every 25 adults living with HIV [38,39] and has been reported together with tuberculosis as leading cause of death in northwest Ethiopia [1]. Nigeria is now the second largest HIV disease burden in the world after South Africa which has 7.1 million (19% of global epidemic) burden of the disease, though prevalence is stable at 3.4% [38,39]. Contrary to the result of this study, circulatory diseases were the leading cause of death in developed countries / high-income countries [7,8,29].

Diseases of the circulatory system (cardiovascular and neurovascular diseases) were the second leading broad ICD-10 cause of death in this study. This finding is similar to that reported by Nwafor and colleagues in southeastern Nigeria [4]. Majority of the deaths due to circulatory diseases were caused by stroke (cerebrovascular accident) (26.7%) and ischaemic heart disease (21.3%). Aside being the chief cause of death due to circulatory diseases, stroke was observed to be the overall second leading individual disease cause of death in this study accounting for 4.2% of all deaths in the study (93/2198) above liver diseases, tuberculosis, diabetes and HIV/AIDS. Similarly, Arodigwe and colleagues have reported stroke as the second leading cause of mortality in southeastern Nigeria [16]. In sub-Saharan Africa, circulatory diseases’ incidence has reached near epidemic proportion with preponderance of stroke, hypertension, cardiomyopathies and rheumatic heart disease reported as chief causes of mortality [40].

Diseases of the digestive system were the 3rd leading broad ICD-10 cause of death in this study. The major contributor to mortality observed in this category is liver diseases. Liver diseases represented the overall 3rd leading cause of death accounting for 4.1% of all deaths recorded in the study only behind sepsis and stroke. Liver diseases has not been implicated in previous studies as top cause of mortality. However, this emerging demographic calls for concern and might not be unconnected to rise in hepatitis B and C [39] which play major role in pathophysiology of most liver diseases. Unlike HIV/AIDS, treatment of hepatitis B and C in Nigeria is still via “out-of-pocket” of the patient. There is no programme for free treatment of both. The observation of this study calls for urgent intervention in this regard.

One of the components of the Sustainable development goals (Millennium Development Goals) is to reduce child mortality [41]. Conditions originating in the perinatal period constituted 5.7% of all causes of mortality, hence, ranking the overall 5th broad cause of mortality. Neonatal death is an important index used in evaluating socioeconomic development as well as an important indicator of status of a community [4,42]. Basically, it reflects the quality of prenatal, delivery and early infant care practices prevalent in any setting [4].

Neoplasms (together with diseases of the respiratory system) were the 7th broad leading cause of death accounting for 5.4% of the observed broad ICD-10 cause of death in this study. The specific diseases mainly involved in the mortality were malignant neoplasm of the breast and liver. This trend is consistent with previous finding in south eastern Nigeria [4]. However, infective agents such as hepatitis B and C are risk factors for the liver neoplasm [43].

Although the ICD-10 broad category of endocrine, nutritional and metabolic diseases ranked the 8th cause of death, diabetes mellitus as a single disease entity ranked the 4th overall cause of death in this study accounting for 3.5% of all deaths. Although Nigeria houses the highest number of persons living with diabetes in Africa [44], the mortality has not been recorded high in the past decades. However, a more recent (2016) WHO report documented diabetes mellitus as being responsible for 2% of all deaths in Nigeria [45]. The growing mortality due to diabetes as observed in this study is an indication of transition in disease burden. This is possibly due to rapidly changing demographic trends, increasing rate of urbanization and transient adoption of western life style in many African settings [46,47].

Malaria, diarrhea & gastroenteritis, acute pharyngitis were the top causes of admission in children in this study. This finding is similar to previous studies in Nigeria that reported malaria, diarrhea/gastrointestinal diseases as the top causes of child morbidity in Bayelsa [48] and Delta [49] states, Nigeria. On the other hand, sepsis, chronic diseases of the tonsil and adenoids and malaria were the leading causes of death in children in this study. Similar to the finding of this study, Duru and colleagues have reported anemic heart failure (19.6%), sepsis (12.8%) and diarrhea (11.3%) as the leading causes of child death in Bayelsa State [48], while Muoneke and colleagues reported malaria (37.5%), gastroenteritis (23.6%) and broncho pneumonia (15.3%) as the leading causes of death in Ebonyi State [50]. Similarly, Ezeonwu et al., have reported malaria (24.4%), sepsis (19.9%) and respiratory infections (7.7%) as the top causes of child mortality in Delta State [49]. Sepsis is life threatening organ dysfunction caused by deregulated host response to infection [51]. Bacteria (gram positive and gram negative) are the chief culprits of sepsis [52]. However, fungi causes do occur [53]. Chronic diseases of the tonsils and adenoids are inflammatory conditions resulting from proliferation and infection of adenoids and tonsils by bacterial agents. The chief bacterial culprits are Haemophilus influenza, Streptococcus pneumonia, Staphylococcus aureus and more [54]. On the other hand, malaria is caused by protozoa of the genus plasmodium specie and transmitted by female anopheles mosquito [55,56]. Diarrhea and gastroenteritis are mainly caused by rotavirus, norovirus, Salmonella, E. coli, campylobacter and others [57]. The above listed diseases are mostly preventable via simple and less cost effective measures. While sepsis and diarrhea can be ameliorated via application of simple hygiene practice, diseases of tonsils and adenoids can be reduced by childhood vaccination against some of the causative agents such as Haemophilus influenza and Streptococcus spp [48]. More so, malaria can be prevented by the use of insecticide treated bed nets and malaria chemoprophylaxis [48,58].

On the part of the adults, the leading causes of hospital admissions were single spontaneous delivery, fetus affected by maternal factors and post-partum hemorrhage (which are all obstetric issues) and diabetes. Although diabetes mellitus was the top non obstetric cause of admission, it did not contribute to the top causes of mortality in adults. On the other hand, sepsis, stroke and liver diseases were the leading causes of death in adults in this study. While sepsis is uncontrolled immunological response to infection, stroke is a cerebrovascular accident that leads to loss of brain function due to disruption of blood supply to the brain [59]. Sepsis is a major cause of death in children and adults. There were an estimated 10 million sepsis related deaths globally in 2017 with higher inclination in low- and middle-income countries [60]. Improved hand hygiene practice have been documented to reduce the incidence and consequent mortality due to sepsis [61]. On the other hand, stroke is mainly disease of the adult. Age is a strong determinant of stroke and the risk doubles every decade above age 55 [62].

It is pertinent to know that malaria is the top cause of morbidity and the third cause of mortality in children, whereas same did not apply to adults. In malaria endemic regions, several acquired and adaptive immunity have been documented [63,64]. These adaptive immunity are more developed and advanced in adults.

Amenable mortality implies deaths due to causes that otherwise shouldn’t result to death in the presence of effective medical practice [2]. It is an indicator of national levels of personal health care access and quality [5]. The high level of mortality from infectious diseases and conditions originating from perinatal period reflects low access to quality health care in the studied population. This observation could be attributed to low contribution to health expenditure by Nigerian government. The Financial Global Health database capped Nigeria health expenditure at $71 per person with 8.5% ($6) from development for assistance for health, 14.1% ($10) from government health spending, 76.1% ($54) from out-of-pocket spending and 1.4% ($1) from prepaid private spending [30].

Although infectious diseases constituted the majority of the causes of death observed in this study, diseases of the circulatory system recorded the highest mortality rate (13.7%) in relation to infectious diseases that had 10.1%. This is an indication for need to improve in research, practice, provision of facilities and policies in the area of circulatory / cardiovascular diseases.

Limitations

The result of this study is potentially prone to varying limitations. Firstly, the study took a retrospective approach, hence, inherent limitations of retrospective studies such as selective bias might not be ruled out. More so, exact causes of death were based on clinical and ancillary investigations rather than postmortem examination (autopsy). Autopsy is not a common norm in the studied area due to some cultural dogmas except in cases of conflict or jurisprudence. Also, labour and delivery may have favored higher admission in females.

Conclusion

The data in this study showed infectious disease and circulatory system diseases as the major causes of mortality in the studied population which reflects the common mortality pattern in developing countries. Aside sepsis, stroke was the second leading cause of mortality. The study revealed double burden of both communicable and non-communicable diseases. However, Infectious and parasitic diseases, Condition originating in the perinatal period, Respiratory system diseases were the leading causes of morbidity, with malaria being the chief individual cause of morbidity. Septicaemia, chronic disease of the tonsils and adenoids and malaria were the chief causes of mortality in children, while sepsis, stroke and liver diseases were the leading causes of death in adults. We thus recommend simultaneous intervention in circulatory diseases alongside with infectious diseases.

Supporting information

S1 Data

(ZIP)

Acknowledgments

We appreciate Mr. Samuel Oscar, Mrs. Nwaiwu Patience Ndidi and Ms. Uchenwa Mercy for their meticulous role in data entering in this study.

Abbreviations

AIDS

Acqured Immune Deficiency Syndrome

HIV

Human immunodeficiency virus

ICD

International Classification of Diseases

MDR

Multidrug resistance

TB

Tuberculosis

UCTH

University of Calabar Teaching Hospital

WHO

World health organization

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Kebede Y, Andargie G, Gebeyehu A, Awoke T, Yitayal M, Mekonnen S. Tuberculosis and HIV are the leading cause of adult death in northwest Ethiopia; evidence from verbal autopsy data of Dabat health and demographic surveillance system, 2007–2013. Population Health Metrics. 2017; 15:27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zellweger U, Junker C, Bopp M. Cause of death coding in Switzerland: evaluation based on nationwide individual linkage of mortality and hospital in-patient records. Population Health metrics. 2019; 17:2 10.1186/s12963-019-0182-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rampatige R, Mikkelsen L,Hernandes B, Riley I, lopes AD. Systematic review of statistics on causes of death in hospitals: strengthen the evidence for policy makers. Bull world Health Organ. 2014; 92:807–816. 10.2471/BLT.14.137935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Nwafor CC, Nnoli MA, Abali CC. Causes and pattern of death in a tertiary hospital in south eastern Nigeria. Sahel Medical Journal. 2014;17(3):102–106 [Google Scholar]
  • 5.GBD 2015 Health Care Access and Quality index based on mortality from causes amenable to personal health care in 195 countries territories, 1990–2015: a novel analysis from the global burden of disease study 2015. Lancet. 2017; 390:231–266. 10.1016/S0140-6736(17)30818-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.World Health Organisation (WHO). The top 10 cause of death. www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed July 8, 2019.
  • 7.Institute for Health Metrics and Evaluation (IHME). Findings from the Global Burden of Disease Study 2017. Seatle, WA: IHME, 2018.
  • 8.World Health Organization (WHO). Cause-Specific mortality and Morbidity. World Health Statistics, 2009.
  • 9.Adeole AA, Arowolo OA, Alatise OI, Osasan SA, Basiriye LA, Omoniyi EO, et al. Pattern of death in a Nigeria teaching hospital; 3 decade analysis. African Health Science. 2010; 10:266–272. [PMC free article] [PubMed] [Google Scholar]
  • 10.Adetiyibi A, Akisanya JB, Onadeko BO. Analysis of the causes of death on the medical wards of the University College Hospital, Ibadan over a 14 year period (1960–1973). Trans R Soc Trop Med Hyg. 1976; 70:466–473. 10.1016/0035-9203(76)90131-0 [DOI] [PubMed] [Google Scholar]
  • 11.Ayeni O. Causes of death in an African city. Afr J Med Sci. 1980; 9:130–147. [PubMed] [Google Scholar]
  • 12.Ogun SA, Adelowo OO, Familoni OB, Jaiyesimi AE, Fakoya EA. Pattern and outcome of medical admissions at the Ogun State University Teaching Hospital Sagamu—A three year review. West Afr J Med. 2000; 19:304–308. [PubMed] [Google Scholar]
  • 13.Adekunle O, Olatunde IO, Abdulateef RM. Causes and pattern of death in a tertiary health institution in southwest Nigeria. Niger Postgrad Med J. 2008; 15: 247–250. [PubMed] [Google Scholar]
  • 14.Iliyasu Z, Abubakar IS, Gajida AU. Magnitude and leading cause of in-hospital mortality of Aminu Kano Teaching Hospital, Kano, Northern Nigeria. A 4 –year prospective analysis. Niger J Med. 2010; 19: 400–406. 10.4314/njm.v19i4.61964 [DOI] [PubMed] [Google Scholar]
  • 15.Chijioke A and Kolo PM. Mortality pattern at the adult medical wards of a teaching Hospital in Sub—Saharan Africa. Int J Trop Med. 2009; 4:27–31. [Google Scholar]
  • 16.Arodiwe EB, Nwokediuko SC, Ike SO. Medical causes of death in a teaching hospital in south—eastern Nigeria: a 16 year review. Niger J Clin Pract. 2014; 17:711–716. 10.4103/1119-3077.144383 [DOI] [PubMed] [Google Scholar]
  • 17.Oyira EJ, Ndiok AE, Ademuyiwa IY. Challenges and Nurses job performance in the University of Calabar Teaching Hospital, Calabar Cross River State Nigeria. Sumerianz Journal of Medical and Health Care. 2019;2(9):106–118. [Google Scholar]
  • 18.Ilori IU & Kalu QN. Intensive care admissions and outcome at the University of Calabar Teaching Hospital, Nigeria. J Crit Care. 2012;27(1): 105.e1–4. [DOI] [PubMed] [Google Scholar]
  • 19.Okokon IB, Oku AO, Agan TU, Asibong UE, Essien EJ, Monjok E. An evaluation of the knowledge and utilization of the partograph in the primary, secondary and tertiary care settings in Calabar South-South Nigeria. Int J Family Med. 2014;105853 10.1155/2014/105853 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nwabueze BO. A constitutional history of Nigeria. United Kingdom: C Hurst and Co LTD; 1982. [Google Scholar]
  • 21.Okoroiwu HU, Asemota EA. Blood dodors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria. BMC Health Service Research. 2019;19:510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ekere EF, Useh MF, Okoroiwu HU, Mirabeau TY. Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria. BMC Infectious Disease. 2020;20:5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Central Statistical Services. International Statistical Classification of Disease and Related Health Problems, ICD 10th revision. WHO: 2007. Pp 1–62.
  • 24.Salimuddin A, Areeba E, Syed EA. Mortality pattern in a trust hospital: A hospital based study in Karachi Pakistan. J Pak Med Assoc. 2013,63:1031–1035. [Google Scholar]
  • 25.Ashenafi W, Eshetu F, Asseta N, Oljira L, Dedefo M, Zelalem D, et al. Trend and cause of adult mortality in Kersa health and demographic and surveillance system (Kersa HDSS), eastern Ethiopia: Verbal autopsy method. Population Health Metrics. 2017:15:22 10.1186/s12963-017-0144-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Institute for Health Metrics and Evaluation (IHME). Findings from the Global Burden of Disease Study 2017. Seatle, IHME, 2018.
  • 27.GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of health related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. The lancet. 2018:392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Macantyre S, Hunt K, Sweeting H. Gender differences in health: are things really as simple as they seem? Soc Sci Med. 1996,42:617–624. 10.1016/0277-9536(95)00335-5 [DOI] [PubMed] [Google Scholar]
  • 29.World Health Organization (WHO). The Global Burden of Disease 2004 update. World Health Organization. Geneva.
  • 30.Institute for Health Metrics and Evaluation (IHME). Measuring what matter; Nigeria. www.healthdata.org/nigeria. Accessed July 22, 2019.
  • 31.Rudd KE, Kissoon N, Limmathurotsakul D, Bory S, Mutahunga B, Seymour CW, et al. The global burden of sepsis; barriers and potential solutions. Critical Care. 2018;22:232 10.1186/s13054-018-2157-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.World Health Organization (WHO). Sepsis; key facts. http://who.int/news-room/fact-sheets/detail/sepsis. Accessed July 22, 2019.
  • 33.Korte R, Rehle T, Merkle A. Strategies to maintain health in the third world. Trop Med Parasitol. 1991;42(4): 428–432. [PubMed] [Google Scholar]
  • 34.Akinkuotu A, Roema E, Richardson A. In-hospital mortality rate and HIV: A medical ward review, Lilongwe, Malawi. [DOI] [PubMed]
  • 35.Rodrigues LC, Gomes MGM, Waldman EA. Migration to middle- income countries and tuberculosis- global policies for global economies. Global Health. 2017;13:15 10.1186/s12992-017-0236-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.World Health Organization (WHO). Global tuberculosis report 2015. Geneva: World Health Organization. 2015.
  • 37.The World Bank Group. World Bank Country and Leading Groups. World Bank list of economies, Washington. 2016. http://databank.worldbank.org/data/download/site-content/CLASS.xls. Accessed July 22, 2019.
  • 38.World Health Organization (WHO). Global Health Observatory (GHO) data: http://www.who.int/gho/hiv/en/. Accessed July 22, 2019.
  • 39.Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion transmissible infections (HBV, HCV, Syphilis, HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven year study. BMC Public Health. 2018; 18: 645 10.1186/s12889-018-5555-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kadiri S. Tackling cardiovascular disease in Africa. BMJ 2005;331:711–712. 10.1136/bmj.331.7519.711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.World Health Organization (WHO). Millennium Development Goals (MDGs). http://www.who.int/topics/millennium_development_goals/about/en. Accessed July 22, 2019.
  • 42.Ekure EN, Ezeaka VC, Iroha EO, Egri-Okwaji MT. Neonatal mortality of inborns in the neonatal unit of tertiary centre in Lagos, Nigeria. Nig Quart J Hosp Med. 2005;15-55-58. [Google Scholar]
  • 43.Jemal A, Centre MM, Desantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology, Biomarkers & Prevention. 2010;19(8):1893–1907. [DOI] [PubMed] [Google Scholar]
  • 44.Mezie-Okoye MM. Diabetes in older adults: experience from a rural community in south-east Nigeria. African Journal of Diabetes Medicine. 2013;21(2):45–48. [Google Scholar]
  • 45.World Health Organization WHO). Diabetes country profile 2016. https://www.who.int/diabetes/country-profiles/nga_en.pdf?ua=1. Accessed July 8, 2019.
  • 46.Aliyu AA, Amadu L. Urbanization, Cities, and Health: The Challenges to Nigeria—A Review. Ann Afr Med. 2017;16(4): 149–158. 10.4103/aam.aam_1_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Okafor CI, Gezawa ID, Sabir AA, Raimi TH, Enang O. Obesity, overweight, and underweight among urban Nigerians. Nigerian Journal of Clinical Practice. 2014;17(6):743–749. 10.4103/1119-3077.144389 [DOI] [PubMed] [Google Scholar]
  • 48.Duru C, Peterside O, Akinbami F. Pattern and outcome of admissions as seen in the pediatric emergency ward of the Niger Delta University Teaching Hospital, Bayelsa State. Niger J Paed. 2013;40(3):232–237. [Google Scholar]
  • 49.Ezeonwu BU, Chima OU, Oguonu T, Ikefuna AN, Nwafor IN. Morbidity and mortality pattern of childhood illness seen at the children emergency unit of Federal Medical Centre, Asaba, Nigeria. Ann Med Health Sci Res. 2014;4(Suppl 3):S239–S244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Muoneke UV, Ibekwe RC, Eke CB, Ibekwe MU, Chinawa JM. Mortality among paediatric inpatients in Mile 4 Mission Hospital Abakaliki South-Eastern Nigeria; a retrospective study. Niger J Paed. 2013;40(3):259–263. [Google Scholar]
  • 51.Keeley A, Hine P, Nsutebu E. The recognition and management of sepsis and septic shock; a guide for non-intensivits. Postgraduate Medical Journal. 2017;93:626–634. 10.1136/postgradmedj-2016-134519 [DOI] [PubMed] [Google Scholar]
  • 52.Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10(6):701–706. 10.1586/eri.12.50 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med.2003;348(16):1546–1554. 10.1056/NEJMoa022139 [DOI] [PubMed] [Google Scholar]
  • 54.Zuliani G, Garron M, Gurrola J, Coleman C, Haupert M, Berk R, et al. Identification of adenoid biofilms in chronic rhinositis. International Journal of Otorhinolaryngology. 2006;70(9):1613–1617. [DOI] [PubMed] [Google Scholar]
  • 55.Okafor IM, Okoroiwu HU, Ekechi CA. Hemoglobin S and glucose-6-phosphate dehydrogenase deficiency coinheritance in AS and SS individuals in malaria- endemic region: A study in Calabar, Nigeria. J Global Infect Dis 2019;11:118–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Ekere EF, Mirabeau TY, Okoroiwu HU. Prevalence of asymptomatic malaria in HIV- infected subjects on cotrimoxazole antimalarial prophylaxis attending a tertiary health care center in in Southern Nigeria: a cross sectional study. Germs. 2020;10(1):44–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Florez ID, Veroniki A, Al Khalifah R, Yepes-Nanez JJ, Sierra JM, Vernooij RWM, et al. Coperative effectiveness and safety of interventions for acute diarrhea and gastroenteritis in children: A systematic review and network meta-analysis. PLoS ONE. 13(12):e0207701 10.1371/journal.pone.0207701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.The Nigerian Academy of Science. Reducing maternal and infant mortality in Nigeria (Workshop summary). Nwosu J, Odubanjo MO, Osinusi BO (Eds). Lagos:West African Book Publishers.
  • 59.Robert AA, Zamzani MM. Stroke in Saudi Arabia: a review of recent literature. Pan African Medical Journal. 2014;17:14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DI, et al. Global, regional, and national sepsis incidence, and mortality 1990–2017. Analysis of the Global Burden of Disease Study. The Lancet. 2020;395:200–211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Pruss-Ustun A, Bartram J, Clasen T, et al. Burden of disease from inadequate water, sanitation and hygiene in low- and middle- income settings: a retrogressive analysis of data from 145 countries. Tropical Medicine & International Health. 2014;19(8):894–905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Donkor ES. Stroke in the 21st century; a snapshot of the burden, epidemiology and quality of life. Stroke Res Treat. 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Soe-Soe Khin-Saw-Aye, Htay-Aung, et al. Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar. Trans R Soc Trop Med Hyg.;95(1):81–84. 10.1016/s0035-9203(01)90342-6 [DOI] [PubMed] [Google Scholar]
  • 64.Obi RK, Okangba CC, Nwanebu F. C., Ndubuisi UU and Orji N. M. Premunition in Plasmodium falciparum malaria. African Journal of Biotechnology. 2010;9(10):1397–1401. [Google Scholar]

Decision Letter 0

Chiara Lazzeri

10 Dec 2019

PONE-D-19-27025

CAUSES OF MORBIDITY AND MORTALITY IN A TERTIARY HOSPITAL IN SOUTHERN NIGERIA; A 6 YEAR EVALUATION

PLOS ONE

Dear Mr Okoroiwu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jan 24 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Chiara Lazzeri

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please change your reference to "p=0.000" to "p<0.001" or as similarly appropriate, as p values cannot equal zero

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study is on the causes of morbidity and mortality in a tertiary hospital in Southern Nigeria and a retrospective work.

1. Being a retrospective work, were the authors able to verify accuracy of the diagnosis in each patient’s case notes to ascertain that the diagnosis was same as coded by the records? inputting wrong diagnosis is a common error in most hospitals in developing countries

2. The study was silent on missing data, a common problem with retrospective study.

3. To be more meaningful, the study should reclassify age groups of patients. The study lumped older children and young adult together which is not acceptable. Internationally, pediatric age group is from birth to <18 years; adults is 18 years to 64 years, and the elderly 65 years and above. This will allow for proper determination of leading cause of morbidity and mortality by age. Infectious diseases may not necessarily be the leading cause of morbidity and mortality among adults and elderly as concluded.

3. The study classified stroke as cardiovascular or circulation disease; Stroke is a cerebrovascular disorder and a neurological disorder and presently the leading cause of death in Nigeria like other developing countries. it is the commonest cause of disability. please reclassify stroke appropriately.

Reviewer #2: Given the paucity of data about in-hospital mortality and/or quality in many African countries, the paper does make a contribution to the literature. However, many points need to be clarified and/or expanded upon in order to increase the strength and interest of the article, as detailed below. The conclusions, particularly in the abstract, should also be more solidly explained as to their relation to the findings.

In addition, there are many mistakes in grammar which need to be corrected and I would recommend an editing service to review the manuscript.

Specific comments:

-Abstract conclusion: This does not give the reader a clear understanding of the main point/findings of the paper. It is very general. The meaning of "double burden of communicable and non-communicable diseases" needs to be specified. Also, if the authors wish to argue that most of the deaths in the study are preventable, this needs better supporting arguments in the discussion, as below.

-Methods: is this in-hospital mortality? If not, what duration of follow-up was used?

-Methods: should state whether this includes Labor and Delivery (see below corollary comment re: Discussion section)

-Methods: who determined the cause of death which is coded by ICD-10? The treating physician?

-Results: In the last line of the first paragraph, you stated that "mortality was significantly higher in female gender," however, the data suggest the opposite, and in the discussion section higher male mortality is discussed

-Results: Second paragraph, "647.0% of the patients were admitted via casualty"--the number needs to be correct to 0-100%

-Results: 5th paragraph: the text would be more informative/interesting with a description of what is meant specifically by "conditions originating from the perinatal period"

-Results: Description of which bacterial organisms the most common cause of septicemia would very much improve the strength

-Results: The last paragraph describes the percentage of deaths due to the leading causes listed.

(a) What does a death due to HIV/AIDS mean? Did these patients die from the virus itself (eg, wasting syndrome, etc.) or more likely, due to opportunistic infections? Again would be helpful to outline this more specifically, and if opportunistic infections, which ones?

(b) It would add significant strength and interest to the paper to know: Of the patients admitted with each of these conditions, what proportion died?

-Discussion: In the discussion of higher mortality among males, it would be important to know whether the female admissions/deaths include those admitted for labor and delivery, which would be expected to make the female mortality rate appear lower--eg, most would not be coming in "sick." If this did include L+D, would consider re-analyzing without those admissions to see if the difference in male and female mortality remains.

-Discussion: The commentary on males having less "health conscious" behavior than females seems somewhat like conjecture and should either be removed or re-stated using less definitive language (unless able to support with literature/data)

-Discussion: A rise in Hepatitis B and C is described. Would expand upon this more given that the finding of liver disease as one of the leading causes of death was the most surprising and potentially interesting piece of new information from the study. Can you specify rates of hepatitis viruses among those with liver disease who died in your study? If not, would describe if there are limitations in availability of testing. It would also be worthwhile to discuss how patients with these viral hepatitides are managed what at your facility and/or in Nigeria in general--are treatments available? Is this data suggesting a reason call for more specific resources for HBV and HCV?

-Discussion: the paragraph regarding conditions in the perinatal period and the Millenium Development Goals does not seem well-placed, and it is not clear how what is written here adds to the literature

-Discussion: Breast and liver cancer were described as leading causes of neoplasms, which is stated is consistent with previous findings. Previous findings from where? Similar hospital settings/LMIC's, etc? Should specify. Also, liver cancer as a leading neoplasm provides yet another opportunity to discuss more specifics about viral hepatitis, and connect to the above comments.

-Discussion: The argument that the mortality from infections and "conditions originating in the perinatal period" reflects low access to quality health care and reflects "amenable mortality" needs to be better supported and explained. As currently written, this reads as an assumption. Ideas include concepts such as: Preventable at what stage? If a patient presents with late-stage septic shock, just because there was an infectious cause does not necessarily mean this death could be prevented even with maximal quality of care at hospital presentation, etc.

-Discussion: I found the discussion about malaria as a cause of morbidity distracting, since the paper is focused on mortality

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Prof E.O. Sanya

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 25;15(8):e0237313. doi: 10.1371/journal.pone.0237313.r002

Author response to Decision Letter 0


24 Jul 2020

Response to review comments

Reviewer #1: The study is on the causes of morbidity and mortality in a tertiary hospital in Southern Nigeria and a retrospective work.

1. Being a retrospective work, were the authors able to verify accuracy of the diagnosis in each patient’s case notes to ascertain that the diagnosis was same as coded by the records? inputting wrong diagnosis is a common error in most hospitals in developing countries

Response:

They authors did not verify via case notes. The trained staff at health records departments do record same from case notes and submit same quarterly to Medical Advisory Committee.

2. The study was silent on missing data, a common problem with retrospective study.

Response:

There was none in the report retrieved based on information used.

3. To be more meaningful, the study should reclassify age groups of patients. The study lumped older children and young adult together which is not acceptable. Internationally, pediatric age group is from birth to <18 years; adults is 18 years to 64 years, and the elderly 65 years and above. This will allow for proper determination of leading cause of morbidity and mortality by age. Infectious diseases may not necessarily be the leading cause of morbidity and mortality among adults and elderly as concluded.

Response:

There was a mistake in the labelling earlier on children. Same has been corrected children age properly listed.

3. The study classified stroke as cardiovascular or circulation disease; Stroke is a cerebrovascular disorder and a neurological disorder and presently the leading cause of death in Nigeria like other developing countries. it is the commonest cause of disability. please reclassify stroke appropriately.

Response:

The suggestion has been done.

Reviewer #2: Given the paucity of data about in-hospital mortality and/or quality in many African countries, the paper does make a contribution to the literature. However, many points need to be clarified and/or expanded upon in order to increase the strength and interest of the article, as detailed below. The conclusions, particularly in the abstract, should also be more solidly explained as to their relation to the findings.

In addition, there are many mistakes in grammar which need to be corrected and I would recommend an editing service to review the manuscript.

Response:

We have put more effort to rid off typological errors and mistakes.

Specific comments:

-Abstract conclusion: This does not give the reader a clear understanding of the main point/findings of the paper. It is very general. The meaning of "double burden of communicable and non-communicable diseases" needs to be specified. Also, if the authors wish to argue that most of the deaths in the study are preventable, this needs better supporting arguments in the discussion, as below.

Response:

We have added explanation to the earlier statement.

-Methods: is this in-hospital mortality? If not, what duration of follow-up was used?

Response:

It is an in-hospital mortality. Further details has been provided in the methods section.

-Methods: should state whether this includes Labor and Delivery (see below corollary comment re: Discussion section)

Response:

This information has been added.

-Methods: who determined the cause of death which is coded by ICD-10? The treating physician?

Response:

The attending physicians did. This information has been added to the method section.

-Results: In the last line of the first paragraph, you stated that "mortality was significantly higher in female gender," however, the data suggest the opposite, and in the discussion section higher male mortality is discussed

Response:

The error has been corrected.

-Results: Second paragraph, "647.0% of the patients were admitted via casualty"--the number needs to be correct to 0-100%

Response:

The error has been corrected.

-Results: 5th paragraph: the text would be more informative/interesting with a description of what is meant specifically by "conditions originating from the perinatal period"

Response:

This is the terminology for the ICD-10 classification of the group. Details has been done in the new part of the discussion added as the mortality discussion was done for children and adults separately.

-Results: Description of which bacterial organisms the most common cause of septicemia would very much improve the strength

Response:

This information has been added in the discussion.

-Results: The last paragraph describes the percentage of deaths due to the leading causes listed.

(a) What does a death due to HIV/AIDS mean? Did these patients die from the virus itself (eg, wasting syndrome, etc.) or more likely, due to opportunistic infections? Again would be helpful to outline this more specifically, and if opportunistic infections, which ones?

(b) It would add significant strength and interest to the paper to know: Of the patients admitted with each of these conditions, what proportion died?

Response:

We have used complications of HIV/AIDS. We do not have data on specific complications and how many died for each.

-Discussion: In the discussion of higher mortality among males, it would be important to know whether the female admissions/deaths include those admitted for labor and delivery, which would be expected to make the female mortality rate appear lower--eg, most would not be coming in "sick." If this did include L+D, would consider re-analyzing without those admissions to see if the difference in male and female mortality remains.

Response:

We have stated this in the methods and as well as in the discussion. We were not able to re stratify data deleting obstetric cases. Entered as part of the limitations.

-Discussion: The commentary on males having less "health conscious" behavior than females seems somewhat like conjecture and should either be removed or re-stated using less definitive language (unless able to support with literature/data)

Response:

This has been deleted.

-Discussion: A rise in Hepatitis B and C is described. Would expand upon this more given that the finding of liver disease as one of the leading causes of death was the most surprising and potentially interesting piece of new information from the study. Can you specify rates of hepatitis viruses among those with liver disease who died in your study? If not, would describe if there are limitations in availability of testing. It would also be worthwhile to discuss how patients with these viral hepatitides are managed what at your facility and/or in Nigeria in general--are treatments available? Is this data suggesting a reason call for more specific resources for HBV and HCV?

Response:

The suggestion has been inputed. However, we do not have information on rate of hepatitis virus in the subjects with liver diseases.

-Discussion: the paragraph regarding conditions in the perinatal period and the Millenium Development Goals does not seem well-placed, and it is not clear how what is written here adds to the literature

Response:

We have placed it properly.

-Discussion: Breast and liver cancer were described as leading causes of neoplasms, which is stated is consistent with previous findings. Previous findings from where? Similar hospital settings/LMIC's, etc? Should specify. Also, liver cancer as a leading neoplasm provides yet another opportunity to discuss more specifics about viral hepatitis, and connect to the above comments.

Response:

The location of the finding has been inserted.

-Discussion: The argument that the mortality from infections and "conditions originating in the perinatal period" reflects low access to quality health care and reflects "amenable mortality" needs to be better supported and explained. As currently written, this reads as an assumption. Ideas include concepts such as: Preventable at what stage? If a patient presents with late-stage septic shock, just because there was an infectious cause does not necessarily mean this death could be prevented even with maximal quality of care at hospital presentation, etc.

Response:

More clarification has been done via the new part of discussion in the preventive means to avoid some of the mortalities.

-Discussion: I found the discussion about malaria as a cause of morbidity distracting, since the paper is focused on mortality

Response:

The problem has been rectified by simultaneous discussion of mortality in children and adult in the new part of the discussion introduced.

All corrections, inputs, adjustments and insertions are highlighted in red. Only deletions are not visible.

Attachment

Submitted filename: Response to review comments.docx

Decision Letter 1

Chiara Lazzeri

27 Jul 2020

CAUSES OF MORBIDITY AND MORTALITY AMONG PATIENTS ADMITTED IN A TERTIARY HOSPITAL IN SOUTHERN NIGERIA; A 6 YEAR EVALUATION

PONE-D-19-27025R1

Dear Dr. Okoroiwu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Chiara Lazzeri

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Chiara Lazzeri

3 Aug 2020

PONE-D-19-27025R1

CAUSES OF MORBIDITY AND MORTALITY AMONG PATIENTS ADMITTED IN A TERTIARY HOSPITAL IN SOUTHERN NIGERIA; A 6 YEAR EVALUATION

Dear Dr. Okoroiwu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Chiara Lazzeri

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (ZIP)

    Attachment

    Submitted filename: Response to review comments.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES